We are live on ! Find out more
SRTA

Strata Critical Medical Inc

96 hedge funds and large institutions have $195M invested in Strata Critical Medical Inc in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 18

23% more funds holding

Funds holding: 7896 (+18)

13% more call options, than puts

Call options by funds: $2.66M | Put options by funds: $2.36M

12% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 17

9.2% more ownership

Funds ownership: 46.16%55.36% (+9.2%)

29% less capital invested

Capital invested by funds: $275M → $195M (-$80.7M)

Holders
96
Holders Change
+18
Holders Change %
+23.08%
% of All Funds
1.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
19
Reduced
17
Closed
18
Calls
$2.66M
Puts
$2.36M
Net Calls
+$304K
Net Calls Change
-$949K
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$54.1M -$3.77M -521,958 -6%
HVCM
2
HG Vora Capital Management
New York
$35.1M
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$22M +$35.6M +4,927,535 New
NAMA
4
Nikko Asset Management Americas
New York
$21.4M +$366K +50,669 +1%
BlackRock
5
BlackRock
New York
$16.5M +$20.5M +2,841,348 +327%
Vanguard Group
6
Vanguard Group
Pennsylvania
$12.3M +$202K +27,946 +1%
State Street
7
State Street
Massachusetts
$8.16M -$7.64M -1,058,082 -37%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$4.24M +$3.64M +504,666 +113%
EMG
9
ETF Managers Group
New Jersey
$3.26M -$636K -88,094 -11%
Northern Trust
10
Northern Trust
Illinois
$2.07M +$2.76M +382,965 +477%
AWS
11
AJ Wealth Strategies
New York
$1.66M
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$1.05M -$938K -129,953 -36%
N
13
Nuveen
North Carolina
$947K +$1.53M +212,387 New
QOP
14
Quinn Opportunity Partners
Virginia
$861K -$891K -123,516 -39%
CF
15
Cantor Fitzgerald
New York
$745K +$433K +60,000 New
IP
16
Intellectus Partners
California
$723K +$1.17M +162,215 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$685K +$983K +136,139 +783%
Citadel Advisors
18
Citadel Advisors
Florida
$634K +$501K +69,479 +96%
Charles Schwab
19
Charles Schwab
California
$629K +$890K +123,296 +695%
SAM
20
Stansberry Asset Management
Texas
$463K -$510K -70,659 -40%
Swiss National Bank
21
Swiss National Bank
Switzerland
$447K +$723K +100,200 New
AIM
22
Allen Investment Management
New York
$446K
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$378K +$612K +84,765 New
UBS Group
24
UBS Group
Switzerland
$357K +$52.9K +7,336 +10%
JP Morgan Chase
25
JP Morgan Chase
New York
$344K +$322K +44,683 +138%

SRTA Hedge Fund Activity: Q2 2022 in Review

96 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q2 2022, worth a combined $195M — down 29% from $275M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new SRTA positions and 18 closed out — a net gain of 18 holders — while 19 added to existing stakes and 17 trimmed.

The largest buyer was Sumitomo Mitsui Trust Group, opening a new position worth an estimated $35.6M. The largest seller was State Street, cutting an estimated $7.64M.

  • 96 institutional investors held Strata Critical Medical Inc (SRTA) as of Q2 2022, up from 78 in Q1 2022.
  • Funds reported $195M of Strata Critical Medical Inc stock for Q2 2022, down 29% quarter-over-quarter.
  • 36 funds opened new Strata Critical Medical Inc positions in Q2 2022 and 18 closed out, a net change of +18 holders.
  • The largest Strata Critical Medical Inc buyer in Q2 2022 was Sumitomo Mitsui Trust Group, an estimated $35.6M added.
  • The largest Strata Critical Medical Inc seller in Q2 2022 was State Street, an estimated $7.64M sold.

Based on aggregated 13F filings for Q2 2022.